Qibiao Wu

5.2k total citations · 1 hit paper
147 papers, 2.6k citations indexed

About

Qibiao Wu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qibiao Wu has authored 147 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 27 papers in Oncology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qibiao Wu's work include RNA modifications and cancer (13 papers), Traditional Chinese Medicine Analysis (12 papers) and Lung Cancer Treatments and Mutations (10 papers). Qibiao Wu is often cited by papers focused on RNA modifications and cancer (13 papers), Traditional Chinese Medicine Analysis (12 papers) and Lung Cancer Treatments and Mutations (10 papers). Qibiao Wu collaborates with scholars based in Macao, China and United States. Qibiao Wu's co-authors include Elaine Lai‐Han Leung, Xing‐Xing Fan, Xinbing Sui, Cong Xu, Xiaojun Yao, Jue Wang, Chun Xie, Zebo Jiang, Weixing Shen and Jumin Huang and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Qibiao Wu

132 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer

2021 177 citations Zebo Jiang, Wenjun Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qibiao Wu Macao	30	1.2k	505	463	453	301	147	2.6k
Jun Gu China	39	1.9k 1.5×	396 0.8×	634 1.4×	606 1.3×	215 0.7×	123	3.8k
Heng Zhou China	30	1.8k 1.5×	548 1.1×	623 1.3×	316 0.7×	534 1.8×	72	3.1k
Hongzhong Li China	32	1.4k 1.2×	305 0.6×	535 1.2×	769 1.7×	445 1.5×	60	2.9k
Jen‐Yu Hung Taiwan	29	1.1k 0.9×	358 0.7×	356 0.8×	558 1.2×	413 1.4×	77	2.2k
Huan Gao China	26	1.0k 0.9×	627 1.2×	472 1.0×	318 0.7×	154 0.5×	90	2.1k
Anjana Munshi India	31	1.1k 0.9×	252 0.5×	459 1.0×	415 0.9×	205 0.7×	157	2.9k
Gopalakrishnan Ramakrishnan United States	29	1.5k 1.3×	232 0.5×	385 0.8×	440 1.0×	251 0.8×	64	2.9k
Yifeng Zheng China	28	1.2k 1.0×	396 0.8×	447 1.0×	742 1.6×	577 1.9×	72	2.7k
Huafeng Kang China	29	1.3k 1.1×	426 0.8×	728 1.6×	836 1.8×	256 0.9×	132	2.9k

Countries citing papers authored by Qibiao Wu

Since Specialization

Citations

This map shows the geographic impact of Qibiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qibiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qibiao Wu more than expected).

Fields of papers citing papers by Qibiao Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qibiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qibiao Wu. The network helps show where Qibiao Wu may publish in the future.

Co-authorship network of co-authors of Qibiao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qibiao Wu. A scholar is included among the top collaborators of Qibiao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qibiao Wu. Qibiao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Fei, et al.. (2025). The Relationship Between Human Cerebrospinal Fluid Proteins and the Risk of Delirium: A Study Based on Genetic Data. Brain and Behavior. 15(9). e70836–e70836. 1 indexed citations

Wang, Shubo, Ziming Zhao, Lili Yu, et al.. (2025). Identification of Quercetin as a Natural MMP1 Inhibitor for Overcoming Cisplatin Resistance in Epithelial Ovarian Cancer. Journal of Cancer. 16(8). 2578–2594.

Yan, Peiyu, et al.. (2025). Efficacy of Auricular Therapy for Motor Impairment After Stroke: A Systematic Review and Meta‐Analysis. International Journal of Older People Nursing. 20(1). e70006–e70006.

Jiang, Zebo, Qiang He, Liping Kang, et al.. (2025). Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells. Chemical Biology & Drug Design. 105(2). e70070–e70070.

Sun, Jing, Run Shi, Yang Wu, et al.. (2024). Integration of transcriptomic analysis and multiple machine learning approaches identifies NAFLD progression-specific hub genes to reveal distinct genomic patterns and actionable targets. Journal Of Big Data. 11(1). 5 indexed citations

Zhu, Qianru, Ruonan Zhang, Xiaoqing Gu, et al.. (2024). Honokiol enhances the sensitivity of cetuximab in KRAS^G13D mutant colorectal cancer through destroying SNX3-retromer complex. Theranostics. 14(14). 5443–5460. 2 indexed citations

Liu, Ziwei, Fan Xiao, Wei Tao, et al.. (2024). Unleashing the potential: integrating nano-delivery systems with traditional Chinese medicine. Nanoscale. 16(18). 8791–8806. 7 indexed citations

Tu, Gao, et al.. (2024). Discovery of Novel Noncovalent KRAS G12D Inhibitors through Structure-Based Virtual Screening and Molecular Dynamics Simulations. Molecules. 29(6). 1229–1229. 2 indexed citations

Sun, Yitian, Qinyi Li, Guohua Li, et al.. (2024). Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance. Chinese Medicine. 19(1). 110–110. 6 indexed citations

10.

Huang, Xueyuan, et al.. (2024). Unraveling the role of the circadian clock genes in cervical squamous cell carcinoma and endocervical adenocarcinoma: A prognostic indicator for prognostic, immunotherapy response, and chemotherapy sensitivity. Journal of Cancer. 15(9). 2788–2804. 1 indexed citations

11.

Luo, Dan, et al.. (2023). The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma. Frontiers in Bioscience-Landmark. 28(10). 271–271. 6 indexed citations

12.

Xu, Youhua, et al.. (2023). Shuangdan Mingmu Capsule for Diabetic Retinopathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2023(1). 4655109–4655109. 1 indexed citations

13.

Liu, Mengnan, et al.. (2023). Zhilong Huoxue Tongyu capsule inhibits rabbit model of hyperlipidemia and atherosclerosis through NF-κB/NLRP3 signaling pathway. Heliyon. 9(11). e20026–e20026. 2 indexed citations

14.

Luo, Gang, Li Chen, Mingtai Chen, et al.. (2023). Hirudin inhibit the formation of NLRP3 inflammasome in cardiomyocytes via suppressing oxidative stress and activating mitophagy. Heliyon. 10(1). e23077–e23077. 5 indexed citations

15.

Li, Ziyi, Mengnan Liu, Mingtai Chen, et al.. (2023). Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 18(5). e0284877–e0284877. 8 indexed citations

16.

Liu, Mengnan, Gang Yuan, Gang Luo, et al.. (2022). Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 16 indexed citations

17.

Huang, Jumin, Zebo Jiang, Yuwei Wang, et al.. (2020). Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy. Current Opinion in Pharmacology. 54. 1–10. 45 indexed citations

18.

Wu, Qibiao. (2010). Protective Effect of Artificial Musk Preconditioning on Rat Myocardial Ischemic and Reperfusion Injury. 1 indexed citations

19.

Wu, Qibiao. (2010). Effects of artificial musk on hyperlipemia in rats. Zhongguo linchuang yaolixue yu zhiliaoxue. 1 indexed citations

20.

Wu, Qibiao. (2009). Effect of artificial musk on myocardial ischemia in animals. Zhongguo yaolixue tongbao. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact